Laurence Dedeken

1.5k total citations
32 papers, 651 citations indexed

About

Laurence Dedeken is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Laurence Dedeken has authored 32 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Genetics and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Laurence Dedeken's work include Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (13 papers) and Acute Myeloid Leukemia Research (5 papers). Laurence Dedeken is often cited by papers focused on Hemoglobinopathies and Related Disorders (18 papers), Iron Metabolism and Disorders (13 papers) and Acute Myeloid Leukemia Research (5 papers). Laurence Dedeken collaborates with scholars based in Belgium, Canada and Netherlands. Laurence Dedeken's co-authors include Alina Ferster, Cécile Brachet, Sophie Tsépélidis, Fabienne Devreker, Philippe Simon, Anne Delbaere, Isabelle Demeestere, Federica Moffa, Sophie Huybrechts and Phu-Quoc Lê and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Laurence Dedeken

29 papers receiving 630 citations

Peers

Laurence Dedeken
C. E. Jensen United Kingdom
Yung Hang Lam Hong Kong
Kar‐Fai Tam Hong Kong
D. W. Bianchi United States
S Chiodi Italy
Hee Jo Baek South Korea
Laurence Dedeken
Citations per year, relative to Laurence Dedeken Laurence Dedeken (= 1×) peers Javier Monleón

Countries citing papers authored by Laurence Dedeken

Since Specialization
Citations

This map shows the geographic impact of Laurence Dedeken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Dedeken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Dedeken more than expected).

Fields of papers citing papers by Laurence Dedeken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Dedeken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Dedeken. The network helps show where Laurence Dedeken may publish in the future.

Co-authorship network of co-authors of Laurence Dedeken

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Dedeken. A scholar is included among the top collaborators of Laurence Dedeken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Dedeken. Laurence Dedeken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linden, Malaïka Van Der, Christophe Chantrain, Laurence Dedeken, et al.. (2024). Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target. Pediatric Research. 97(1). 160–168.
2.
Dedeken, Laurence, Alina Ferster, Virginie Doyen, et al.. (2024). Pilot study on the use of basophil activation tests and skin tests for the prevention of allergic transfusion reactions. SHILAP Revista de lepidopterología. 4. 1328227–1328227.
3.
Uyttebroeck, Anne, An Van Damme, Laurence Dedeken, et al.. (2022). Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia. Cancers. 14(9). 2098–2098. 5 indexed citations
4.
Gulbis, Béatrice, Fleur Samantha Benghiat, Bénédicte Brichard, et al.. (2021). Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry. Blood. 138(Supplement 1). 4171–4171. 1 indexed citations
5.
Dedeken, Laurence, et al.. (2020). Effective rescue treatment with vemurafenib of an infant with high-risk Langerhans cell histiocytosis. Annales de Dermatologie et de Vénéréologie. 147(11). 782–785. 2 indexed citations
6.
Moerloose, Barbara De, Karl Vandepoele, Anne Uyttebroeck, et al.. (2020). Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach. Pediatric Research. 89(7). 1695–1705. 12 indexed citations
7.
Moerloose, Barbara De, Ardine Reedijk, Geertruida H. de Bock, et al.. (2019). Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01. Pediatric Blood & Cancer. 66(5). e27605–e27605. 23 indexed citations
8.
Rozen, Laurence, Denis F. Noubouossie, Laurence Dedeken, et al.. (2019). Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?. Journal of Clinical Medicine. 8(11). 1796–1796. 2 indexed citations
9.
Dedeken, Laurence, et al.. (2019). Successful transition from paediatric to adult care in sickle cell disease. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 40(6). 495–501. 1 indexed citations
10.
Nagant, Carole, Cyril Barbezange, Laurence Dedeken, et al.. (2019). Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease. PLoS ONE. 14(10). e0223991–e0223991. 11 indexed citations
11.
Lê, Phu-Quoc, Béatrice Gulbis, Laurence Dedeken, et al.. (2015). Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatric Blood & Cancer. 62(11). 1956–1961. 122 indexed citations
12.
Dedeken, Laurence, Phu-Quoc Lê, Cathérine Heijmans, et al.. (2014). Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results from a Cross-Sectional Evaluation in a Single Center in Belgium. PLoS ONE. 9(10). e108922–e108922. 12 indexed citations
13.
Dedeken, Laurence, Phu-Quoc Lê, Laurence Rozen, et al.. (2014). Clinical Benefit and Costs’ Evaluation of Erythocytapheresis Compared to Manual Exchange Transfusion for Children with Sickle Cell Disease: A Single Center Experience. Blood. 124(21). 4091–4091. 2 indexed citations
14.
Rozen, Laurence, Sophie Huybrechts, Laurence Dedeken, et al.. (2013). Transient leukemia in a newborn without Down syndrome: case report and review of the literature. European Journal of Pediatrics. 173(12). 1643–1647. 11 indexed citations
15.
Duval, Michel, et al.. (2013). Risk of Cytomegalovirus Infection and Disease after Umbilical Cord Blood Transplantation in Children. Canadian Journal of Infectious Diseases and Medical Microbiology. 24(1). e11–5. 5 indexed citations
16.
Lê, Phu-Quoc, Laurence Dedeken, Béatrice Gulbis, et al.. (2013). Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy. Blood. 122(21). 2231–2231. 1 indexed citations
17.
Rozen, Laurence, Denis F. Noubouossie, Laurence Dedeken, et al.. (2013). Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia. Blood. 122(21). 2367–2367.
18.
Yates, Amber M., Laurence Dedeken, Matthew P. Smeltzer, et al.. (2012). Hydroxyurea treatment of children with hemoglobin SC disease. Pediatric Blood & Cancer. 60(2). 323–325. 16 indexed citations
19.
Dedeken, Laurence, Phu-Quoc Lê, Nadira Azzi, et al.. (2011). Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Childhood: A Single Center Experience with 45 Patients. Blood. 118(21). 3103–3103. 2 indexed citations
20.
Lê, Phu-Quoc, Alina Ferster, Frédéric Cotton, et al.. (2010). Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.. PubMed. 70(5-6). 467–70. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026